share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

SEC announcement ·  Jun 14 16:06
Summary by Moomoo AI
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more